retatrutide type 1 diabetes Blood Sugar Results: 2.02% A1C Drop in Trials New Kind of Diabetes Drug

But it does mean that consistent delivery is arguably more important, because inconsistent absorption could affect the balance of receptor activation

One notable difference is that tirzepatide is a dual-agonist (GLP-1 and GIP) while retatrutide is a triple-agonist (GLP-1, GIP, and glucagon)

On average, a one-month supply of Wegovy, a brand name of semaglutide GLP-1 injections that is FDA-approved for weight management, costs $1,430

It was a complementary fat-burning lever that added efficacy without the tolerability cost

Your doctor should confirm adequate nutritional status, stable blood sugar control, and no active digestive complications before starting therapy

They named it a triple agonist because it targets GLP-1, GIP, and glucagon receptors